Importantly, the role of the anti-inflammatory cytokine IL-10 in AD brain remains controversial, since recent studies in APP mice suggested that it may inhibit microglial Aβ clearance, promoting Aβ plaque generation and cognitive impairment (rather than delaying AD progression) [109]. The gene discussed is APP; the disease is Cognitive impairment.